Skip to content

The American-European Consensus Conference On Ards. Definitions, Mechanisms, Relevant Outcomes, And Clinical Trial Coordination

Gordon R. Bernard, Antonio Artigas, Kenneth L. Brigham, Jean M. Carlet, Konrad J. Falke, Leonard D. Hudson, Maurice Lamy, Jean Roger Le Gall, Alison Morris, Roger G. Spragg

American Journal of Respiratory and Critical Care Medicine · 1994 · 6,754 citations

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J. M., Falke, K. J., Hudson, L. D., Lamy, M., Gall, J. R. L., Morris, A., & Spragg, R. G. (1994). The american-european consensus conference on ards. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine, 149(3), 818–824. https://doi.org/10.1164/ajrccm.149.3.7509706

In text: (Bernard et al., 1994)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

The acute respiratory distress syndrome (ARDS), a process of nonhydrostatic pulmonary edema and hypoxemia associated with a variety of etiologies, carries a high morbidity, mortality (10 to 90%), and financial cost. The reported annual incidence in the United States is 150,000 cases, but this figure has been challenged, and it may be different in Europe. Part of the reason for these uncertainties are the heterogeneity of diseases underlying ARDS and the lack of uniform definitions for ARDS. Thus, those who wish to know the true incidence and outcome of this clinical syndrome are stymied. The American-European Consensus Committee on ARDS was formed to focus on these issues and on the pathophysiologic mechanisms of the process. It was felt that international coordination between North America and Europe in clinical studies of ARDS was becoming increasingly important in order to address the recent plethora of potential therapeutic agents for the prevention and treatment of ARDS.

  1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)2016
  2. APACHE II1985
  3. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock2001
  4. Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice2017
  5. Surviving Sepsis Campaign2013

Metadata from OpenAlex (CC0). Citations are generated from the published record.